Vascular Access Infection

W. L. Gore & Associates Inc. is acquiring InnAVasc Medical Inc., a medical technology company focused on developing vascular access grafts for patients with end-stage renal disease, according to a press release.

In this video, Timothy Pflederer, MD, president of the Renal Physicians Association, spoke about the payment cuts some vascular specialists will face when treating Medicare patients for access complications.

I find it valuable to conduct an introspection of our specialty – and ourselves – amid our daily efforts to assess patients with chronic kidney disease and to provide treatment.

Nephrologists and the kidney care team need to improve efforts at educating patients about dialysis.

Xeltis, a Swiss-Dutch medical device company, reported that it implanted patients with kidney failure who required dialysis with aXess, the first restorative synthetic hemodialysis access graft.

Buttonhole cannulation is associated with a higher risk for vascular access-related infection than rope-ladder cannulation in patients on in-center hemodialysis, according to a published study.